Yale-Brown Obsessive Compulsive Scale – Self-Report (Y-BOCS-SR)

1. Abstract

The Yale-Brown Obsessive Compulsive Scale – Self-Report (Y-BOCS-SR) represents the self-administered adaptation of the clinician-rated Yale-Brown Obsessive Compulsive Scale (Y-BOCS), widely recognized across clinical psychiatry and behavioral neuroscience as the gold-standard instrument for quantifying the severity of obsessive-compulsive disorder (OCD) symptoms. Designed to measure symptom magnitude independently of the specific thematic content of a patient’s obsessions or compulsions, the scale operationalizes obsessive-compulsive severity across five core phenotypic dimensions: time occupied, functional interference, subjective distress, active resistance, and degree of control. The instrument comprises 10 primary severity items split evenly into two five-item subscales: the Obsessions Severity Subscale (Items 1–5) and the Compulsions Severity Subscale (Items 6–10).

Each item is rated on a 5-point Likert scale ranging from 0 (no symptoms/complete control) to 4 (extreme symptoms/complete lack of control), generating a composite global score from 0 to 40, alongside domain-specific subscale totals ranging from 0 to 20. Extensive psychometric evaluations demonstrate high internal consistency across diverse clinical cohorts, with Cronbach’s alpha typically ranging between .86 and .93 for the total score, and test-retest reliability coefficients exceeding .85 across intervals ranging from one to two weeks. Convergent validity with clinician-rated Y-BOCS interviews is exceptionally strong (Pearson’s r = .78 to .91), indicating that the self-report modality captures symptom burden with fidelity comparable to expert clinical assessment while drastically minimizing administrative burden in large-scale psychopharmacological trials, epidemiologic investigations, and routine psychiatric outcome monitoring.

2. Keywords

Yale-Brown Obsessive Compulsive Scale, Y-BOCS-SR, Obsessive-Compulsive Disorder, Psychometrics, Self-Report, Severity Measurement, Exposure and Response Prevention, Obsessions, Compulsions, Clinical Assessment

3. Authors

The original clinician-administered Yale-Brown Obsessive Compulsive Scale was developed by an interdisciplinary team of clinical psychiatrists and neuropsychopharmacologists at Yale University School of Medicine and Brown University:

• Wayne K. Goodman, M.D. — Department of Psychiatry, Yale University School of Medicine, New Haven, CT (currently Chair of the Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX). Renowned investigator in psychiatric neuromodulation, obsessive-compulsive neurocircuitry, and translational psychopharmacology.
• Lawrence H. Price, M.D. — Department of Psychiatry, Yale University School of Medicine, New Haven, CT (currently Professor of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI). Clinical expert in mood and anxiety disorders, treatment-resistant psychiatric conditions, and clinical trial design.
• Steven A. Rasmussen, M.D. — Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, RI. Pioneer in identifying phenomenological subtypes of OCD and advancing surgical/deep brain stimulation interventions for intractable psychiatric disorders.
• Collaborating Investigators: C. Mazure, G. R. Heninger, and D. S. Charney (Yale University Clinical Neuroscience Research Unit and Abraham Ribicoff Research Facilities).

The self-report adaptation (Y-BOCS-SR) was subsequently validated and refined through prominent psychometric studies spearheaded by Lee Baer, Ph.D., Gail Steketee, Ph.D., and Michael A. Jenike, M.D. at Massachusetts General Hospital and Boston University, confirming the empirical equivalence and structural fidelity of the paper-and-pencil and electronic self-report formats compared to the semi-structured clinician interview.

4. Purpose

The primary clinical and psychometric objective of the Y-BOCS-SR is to provide a standardized, structurally robust, and time-efficient self-report instrument capable of evaluating obsessive-compulsive symptom severity across psychiatric and research settings. Prior to the introduction of the Y-BOCS framework, clinical measurement of OCD suffered from a fundamental methodological confounding: instruments routinely conflated the breadth or qualitative content of symptoms (e.g., number of specific washing, checking, or counting rituals) with the dimensional severity (e.g., functional impairment and distress) of the illness. Consequently, an individual with a single, disabling checking compulsion occupying ten hours daily might have scored lower on older inventories than an individual with five mild, non-impairing idiosyncrasies. The Y-BOCS-SR circumvents this limitation by dissociating symptom manifestation from severity grading, standardizing the evaluation of obsessive-compulsive phenomena across universal dimensional indices.

In clinical practice, the Y-BOCS-SR serves as an indispensable tool across the continuum of care:

• Baseline Clinical Profiling: It establishes a baseline metric of symptom burden, categorizing patients into distinct severity strata ranging from subclinical manifestation to extreme, incapacitating illness.
• Treatment Response Monitoring: Administered longitudinally, it tracks quantitative trajectories during empirical treatments such as cognitive-behavioral therapy featuring Exposure and Response Prevention (ERP) and pharmacotherapy involving selective serotonin reuptake inhibitors (SSRIs). International consensus criteria define clinical response as a ≥25% to 35% reduction in total Y-BOCS score, and clinical remission as an absolute score ≤12.
• Health Economics and Epidemiological Research: By removing the requirement for a 45-minute clinical interview conducted by a trained diagnostic rater, the Y-BOCS-SR facilitates cost-effective assessment in large-scale clinical trials, genetic linkage consortia, digital mental health platforms, and routine outpatient triage systems.

5. Psychological Construct

The Y-BOCS-SR operationalizes obsessive-compulsive disorder as a multi-dimensional construct defined by the interaction between recurrent, intrusive mental events (obsessions) and repetitive behavioral or mental rituals executed to neutralize distress or prevent feared outcomes (compulsions). Rather than assessing these phenomena globally, the scale dissects obsessions and compulsions across five distinct phenomenological dimensions, generating a granular psychometric profile:

The Obsessions Severity Domain (Items 1–5)

• Time Occupied by Obsessive Thoughts (Item 1): Assesses the chronometric duration and frequency of intrusive thoughts, images, or urges. This parameter distinguishes transient, subclinical intrusive cognitions from pervasive, intractable obsessions that dominate the patient’s daily cognitive landscape.
• Interference Due to Obsessive Thoughts (Item 2): Quantifies functional disruption across vocational, educational, relational, and self-care domains. It captures the degree to which intrusive thoughts hijack working memory, attention, and executive execution.
• Distress Associated with Obsessions (Item 3): Evaluates the affective impact elicited by intrusive thoughts, focusing on subjective anxiety, revulsion, perceived threat, or internal torment.
• Resistance Against Obsessions (Item 4): Probes the active psychological effort invested by the respondent to challenge, suppress, disregard, or redirect attention away from obsessions. In the standard scoring paradigm, lower active resistance signifies either complete demoralization, severe illness chronicity, or poor symptom insight.
• Degree of Control Over Obsessions (Item 5): Quantifies respondents’ perceived efficacy in terminating, arresting, or deflecting obsessive intrusions once initiated, serving as a measure of cognitive control capacity.

The Compulsions Severity Domain (Items 6–10)

• Time Spent Performing Compulsions (Item 6): Measures the total duration devoted to repetitive motor rituals (e.g., hand-washing, ordering, door-checking) or covert mental acts (e.g., neutralizing phrases, silent prayers, somatic counting).
• Interference Due to Compulsions (Item 7): Gauges the real-world behavioral and social impairment precipitated by ritual performance, including missed occupational deadlines, severe social isolation, or chronic domestic friction.
• Distress Associated with Compulsive Prevention (Item 8): Evaluates the magnitude of affective distress, autonomic arousal, or panic that would occur if compulsive behaviors were actively blocked, interrupted, or systematically prevented (a key construct underlying behavioral exposure models).
• Resistance Against Compulsions (Item 9): Documents the conscious voluntary effort exerted to withhold ritualistic execution upon exposure to triggering stimuli. Diminished resistance often correlates with ritual automatization and chronic symptom consolidation.
• Degree of Control Over Compulsions (Item 10): Assesses the subjective involuntary drive behind rituals and the patient’s capacity to arrest or terminate compulsive behaviors once begun.

6. Theoretical Framework

The architectural configuration of the Y-BOCS-SR is grounded in the convergence of cognitive-behavioral theory, neurobiological circuit models, and empirical psychopathology:

Cognitive-Behavioral Theory

The instrument is anchored in the cognitive-behavioral formulation of OCD articulated by Paul Salkovskis and Jack Rachman. Within this model, intrusive thoughts, images, and impulses are ubiquitous phenomenological occurrences across the general population. Pathological obsessions arise not from the intrusions themselves, but from the dysfunctional, catastrophic appraisals attributed to them (e.g., inflated responsibility, thought-action fusion, overestimation of threat, and intolerance of uncertainty). Compulsions emerge as maladaptive behavioral or cognitive neutralization strategies intended to alleviate the distress triggered by catastrophic misinterpretations. The Y-BOCS-SR captures this functional cycle by measuring the direct affective distress elicited by intrusions (Item 3), the behavioral drive to perform compulsions to avert distress (Item 8), and the secondary functional interference resulting from these self-perpetuating neutralization loops (Items 2 and 7).

Cortico-Striato-Thalamo-Cortical (CSTC) Circuit Dysregulation

From a neurobiological standpoint, the dimensions indexed by the Y-BOCS-SR reflect dysregulation within frontostriatal networks, specifically the cortico-striato-thalamo-cortical (CSTC) loop involving the orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), and striatum (caudate nucleus). In neuroimaging investigations, elevated scores on the Y-BOCS Time and Resistance items strongly correlate with hyperactivation in the OFC and ventral striatum during error detection and symptom provocation tasks. Structural and functional alterations within the dorsolateral prefrontal cortex (dlPFC) correspond directly with compromised performance on Item 5 (Control Over Obsessions) and Item 10 (Control Over Compulsions), reflecting impairments in top-down inhibitory control and cognitive flexibility.

7. Validity

The validity of the Y-BOCS-SR has been empirically established across diverse clinical, non-clinical, and cross-cultural cohorts:

Construct and Convergent Validity

Convergent validity is documented through robust correlations with the clinician-administered Y-BOCS interview. Studies by Steketee et al. (1996), Baer et al. (1993), and Rosenfeld et al. (1992) reported correlation coefficients between self-report total scores and clinician-derived scores ranging from r = .78 to r = .91 across treatment-seeking samples. Strong convergent associations are consistently observed with alternative OCD assessment batteries, including the Obsessive-Compulsive Inventory-Revised (OCI-R) (r = .68 to .77) and the Padua Inventory-Washington State University Revision (PI-WSUR) (r = .62 to .74).

Discriminant Validity

The scale demonstrates acceptable discriminant validity when contrasted against generalized affective and neurotic constructs. Although moderate correlations exist between the Y-BOCS-SR total score and measures of generalized depression and anxiety—such as the Beck Depression Inventory-II (BDI-II) (r = .40 to .55) and the Beck Anxiety Inventory (BAI) (r = .42 to .58)—these relationships reflect the known high comorbidity between OCD, major depressive disorder, and secondary anxiety states. When controlling for general negative affect, the Y-BOCS-SR retains its ability to differentiate OCD cohorts from individuals with panic disorder, generalized anxiety disorder, and healthy controls (p < .001).

Treatment Sensitivity and Predictive Validity

The Y-BOCS-SR exhibits high sensitivity to therapeutic change. Randomized controlled trials evaluating pharmacological agents (such as fluoxetine, sertraline, and fluvoxamine) and behavioral protocols (such as manualized ERP) demonstrate that reductions in Y-BOCS-SR scores parallel clinician ratings throughout double-blind treatment phases (Cohen’s d effect sizes ranging from 0.95 to 1.62). The instrument reliably identifies post-intervention functional status, with reductions in subscale scores predicting long-term relapse prevention and quality of life restoration.

8. Reliability

The psychometric reliability of the Y-BOCS-SR has been corroborated across numerous clinical trials and normative psychometric validations:

Internal Consistency

The scale consistently exhibits strong internal consistency across clinical settings:

• Total Scale: Cronbach’s α coefficients consistently range between .86 and .93, reflecting a cohesive overarching measurement of obsessive-compulsive severity. McDonald’s ω total yields comparable values (.88 to .94).
• Obsessions Subscale: Internal consistency estimates for Items 1–5 range from α = .80 to .88.
• Compulsions Subscale: Internal consistency estimates for Items 6–10 range from α = .82 to .89.

Test-Retest Reliability and Stability

Temporal stability evaluations demonstrate substantial consistency when reassessed during periods of symptom stability:

• Short-term Stability (1–7 days): Intraclass correlation coefficients (ICC) range between .88 and .94 in untreated clinical samples.
• Medium-term Stability (2–4 weeks): Pearson test-retest correlation coefficients range between .81 and .87, confirming measurement stability in the absence of therapeutic intervention.
• Inter-Method Concordance: The item-by-item concordance between clinician-administered ratings and self-reported responses demonstrates weighted kappa coefficients (κ_w) ranging from .64 to .82, confirming that patient self-appraisal closely approximates clinical assessment.

9. Factor Analysis

Structural investigations of the Y-BOCS and Y-BOCS-SR using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) have clarified the underlying dimensionality of the 10-item scale:

Two-Factor Model (Obsessions vs. Compulsions)

The theoretically hypothesized structure posits a two-factor latent model aligning with the clinical division of symptoms:

• Factor 1: Obsessions Severity (Items 1 through 5), with standardized factor loadings ranging from .62 to .86.
• Factor 2: Compulsions Severity (Items 6 through 10), with standardized factor loadings ranging from .65 to .89.

While this model exhibits acceptable fit in several initial psychometric trials, empirical CFA evaluations frequently indicate elevated residual covariance between parallel items (e.g., Item 1 [Obsession Time] and Item 6 [Compulsion Time]; Item 4 [Obsession Resistance] and Item 9 [Compulsion Resistance]).

Alternative Three-Factor and Bifactor Models

Subsequent structural equation modeling investigations across large clinical cohorts (e.g., McKay et al., Storch et al., Amir et al.) identified an alternative three-factor configuration that often yields superior fit indices:

• Severity / Disturbance Factor: Encompassing Time, Interference, and Distress across both obsessions and compulsions (Items 1, 2, 3, 6, 7, and 8). Standardized loadings on this core pathology factor typically exceed .75.
• Resistance Factor: Composed of Item 4 and Item 9, capturing active behavioral resistance against intrusive thoughts and compulsive drives.
• Control Factor: Composed of Item 5 and Item 10, assessing successful subjective control over cognitive and motor phenomena.

Fit parameters for this three-factor framework and corresponding bifactor models demonstrate good alignment with contemporary psychometric benchmarks: Comparative Fit Index (CFI) > .95, Tucker-Lewis Index (TLI) > .94, Root Mean Square Error of Approximation (RMSEA) ≤ .055 (90% CI: .041–.068), and Standardized Root Mean Square Residual (SRMR) ≤ .045.

10. Instrument / Measurement Tool

• Instrument Name: Yale-Brown Obsessive Compulsive Scale – Self-Report (Y-BOCS-SR)
• Instrument Type: Self-administered clinical severity rating scale
• Target Population: Adolescents and adults (≥16 years) with diagnosed, suspected, or subthreshold obsessive-compulsive disorder
• Administration Modality: Paper-and-pencil questionnaire, clinical kiosk terminal, or secure digital web/mobile interface
• Average Completion Duration: 8 to 12 minutes
• Number of Primary Items: 10 severity items (Items 1–5: Obsessions; Items 6–10: Compulsions)
• Authentic Response Scale: 5-point Likert scale (0 to 4 for each item; specific response options vary by item dimension, ranging from 0 = None / No symptoms / Complete control to 4 = Extreme / Constant / Complete lack of control)
• Scoring Architecture:
  • Obsessions Subscale Score: Sum of Items 1 through 5 (Score Range: 0 to 20)
  • Compulsions Subscale Score: Sum of Items 6 through 10 (Score Range: 0 to 20)
  • Global Total Score: Sum of all 10 items (Score Range: 0 to 40)
  • Scoring Directionality: Items 4, 5, 9, and 10 evaluate resistance and control where higher scores denote greater clinical impairment (e.g., lower resistance or deficient control)
• Clinical Severity Stratification Guidelines:
  • 0–7: Subclinical symptom burden
  • 8–15: Mild obsessive-compulsive disorder
  • 16–23: Moderate obsessive-compulsive disorder (typical clinical trial inclusion threshold: ≥16)
  • 24–31: Severe obsessive-compulsive disorder
  • 32–40: Extreme / incapacitating obsessive-compulsive disorder

11. Permissions & Fee and Test Year

The clinician-administered Yale-Brown Obsessive Compulsive Scale (Y-BOCS) was originally published in 1989 by Wayne K. Goodman, Lawrence H. Price, Steven A. Rasmussen, and colleagues in the Archives of General Psychiatry. The self-report version (Y-BOCS-SR) was developed and validated in the early 1990s through collaborative research teams led by Lee Baer, Gail Steketee, and colleagues.

The 10-item severity scale is widely treated within the global scientific, academic, and clinical research communities as an accessible clinical assessment tool for non-profit research, academic investigation, and individual clinical practice. However, commercial utilization—including integration into proprietary corporate digital health applications, commercial clinical trials sponsored by pharmaceutical corporations, or distribution within fee-for-service enterprise medical record ecosystems—may require formal permission, translation certification, or licensing agreements from the intellectual property holders or copyright-retaining institutions. Researchers and institutional clinicians should verify institutional policy prior to large-scale deployment.

12. References

Amir, N., Foa, E. B., & Coles, M. E. (1997). Factor structure of the Yale-Brown Obsessive Compulsive Scale. Psychological Assessment, 9(1), 44–48. https://doi.org/10.1037/1040-3590.9.1.44

Baer, L., Brown-Beasley, M. W., Sorce, J., & Henriques, A. I. (1993). Computer-assisted telephone administration of a structured interview for obsessive-compulsive disorder. The American Journal of Psychiatry, 150(11), 1737–1738. https://doi.org/10.1176/ajp.150.11.1737

Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Delgado, P., Heninger, G. R., & Charney, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale: II. Validity. Archives of General Psychiatry, 46(11), 1012–1016. https://doi.org/10.1001/archpsyc.1989.01810110054008

Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., Heninger, G. R., & Charney, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Archives of General Psychiatry, 46(11), 1006–1011. https://doi.org/10.1001/archpsyc.1989.01810110048007

McKay, D., Danyko, S. J., Neziroglu, F., & Yaryura-Tobias, J. A. (1995). Factor structure of the Yale-Brown Obsessive-Compulsive Scale: A critical review. Depression and Anxiety, 2(3), 115–123. https://doi.org/10.1002/da.10002

Rosenfeld, R., Dar, R., Anderson, D., Kobak, K. A., & Greist, J. H. (1992). A computer-administered version of the Yale-Brown Obsessive-Compulsive Scale. Psychological Assessment, 4(3), 329–332. https://doi.org/10.1037/1040-3590.4.3.329

Salkovskis, P. M. (1985). Obsessional-compulsive problems: A cognitive-behavioural analysis. Behaviour Research and Therapy, 23(5), 571–583. https://doi.org/10.1016/0005-7967(85)90105-6

Steketee, G., Frost, R., & Bogart, K. (1996). The Yale-Brown Obsessive Compulsive Scale: Interview versus self-report. Behaviour Research and Therapy, 34(8), 675–684. https://doi.org/10.1016/0005-7967(96)00036-8

Storch, E. A., Shapira, N. A., Dim شنا, A., Murphy, T. K., & Goodman, W. K. (2005). Psychometric evaluation of the Yale-Brown Obsessive Compulsive Scale—Second Edition. Depression and Anxiety, 22(4), 198–205. https://doi.org/10.1002/da.20100

13. Items of the Scale (Questionnaire)